Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 152,915 | 114,617 | 1,193,323 | 307,711 | 165,436 |
| Cost of Goods | 19,477 | 21,374 | 24,412 | 30,547 | 30,215 |
| Gross Profit | 133,438 | 93,243 | 1,168,911 | 277,164 | 135,221 |
| Operating Expenses | 559,026 | 533,652 | 481,391 | 337,353 | 248,291 |
| Operating Income | -425,111 | -440,035 | 687,932 | -59,642 | -112,855 |
| Interest Expense | 37,118 | 46,354 | 42,778 | 40,954 | 42,180 |
| Other Income | 18,282 | 46,335 | 37,571 | 4,520 | 2,387 |
| Pre-tax Income | -443,947 | -440,054 | 682,725 | -96,076 | -152,648 |
| Income Tax | 493 | 613 | 1,412 | 616 | 876 |
| Net Income Continuous | -444,440 | -440,667 | 681,313 | -96,692 | -153,524 |
| Net Income | $-444,440 | $-440,667 | $681,313 | $-96,692 | $-153,524 |
| EPS Basic Total Ops | -37.33 | -37.78 | 60.27 | -9.30 | -16.49 |
| EPS Basic Continuous Ops | -37.31 | -37.75 | 60.23 | -9.30 | -16.49 |
| EPS Diluted Total Ops | -37.33 | -37.78 | 56.67 | -9.30 | -16.49 |
| EPS Diluted Continuous Ops | -37.31 | -37.75 | 56.71 | -9.30 | -16.49 |
| EPS Diluted Before Non-Recurring Items | -33.58 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-410,929 | $-438,273 | $698,802 | $-44,901 | $-97,504 |